Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
1 - 10 of 62
- IOF mandate Limburg Clinical Research Center (LCRC) 2024-2028From1 Jan 2024 → TodayFunding: IOF - mandates
- Structural funding of the LCRC centerFrom1 Jan 2024 → TodayFunding: BOF - research organisations
- Return to work through primary care: The development of a toolkit for general practitionersFrom1 Jan 2024 → TodayFunding: Department of Economy, Science and Innovation
- Donation agreement between Hasselt University, Mylan EPD BV and Noorderhart vzw regarding UMSC.From20 Dec 2022 → 20 Apr 2023Funding: Nonprofit institution or equivalents
- Integrated approach through first-line zones for reintegration into the labor market among the long-term sickFrom19 Dec 2022 → 18 Dec 2023Funding: Department of Economy, Science and Innovation
- Translational MS research UMSC.From29 Sep 2022 → 31 Dec 2022Funding: Industrial enterprises
- Unravelling the mechanism of single time vaccination strategy (SinTimVaS)From21 Feb 2022 → 31 Dec 2022Funding: BOF - projects
- NEURONET - Phase IIIFrom1 Feb 2022 → TodayFunding: BOF - Methusalem
- Deep immune-phenotyping of multiple sclerosis patients using advanced spectral flow cytometryFrom1 Jan 2022 → 31 Dec 2023Funding: Foundations, funds and other with scientific goal
- DigiPath: The introduction of digital pathology in LimburgFrom16 Dec 2021 → TodayFunding: Provinces, Own budget, for example: patrimony, inscription fees, gifts
Publications
31 - 40 of 158
- Leukemia inhibitory factor tips the immune balance towards regulatory T cells in multiple sclerosis(2015)
Authors: Kris JANSSENS, C. Van den Haute, Veerle Baekelandt, S. Lucas, Jack VAN HORSSEN, Bart VAN WIJMEERSCH, Piet STINISSEN, Niels HELLINGS, Jerome HENDRIKS, Leen SLAETS, et al.
Pages: 180 - 188 - Circulating Follicular Regulatory T Cells Are Defective in Multiple Sclerosis(2015)
Authors: Tessa DHAEZE, Evelyn PEELEN, Anneleen Hombrouck, Liesbet PEETERS, Bart VAN WIJMEERSCH, Nele LEMKENS, Peter LEMKENS, Veerle SOMERS, Sophie Lucas, Bieke BROUX, et al.
Pages: 832 - 840 - Aged B-cells with proinflammatory and autoreactive characteristics are expanded in a proportion of MS patients(2015)
Authors: Nele CLAES, Judith FRAUSSEN, Piet STINISSEN, B. Vanwijmeersch, R. Hupperts, Veerle SOMERS
Pages: 789 - 789 - Neuroinflammatory signals enhance the immunomodulatory and neuroprotective properties of multipotent adult progenitor cells(2015)
Authors: Stelios RAVANIDIS, Jeroen BOGIE, Raf DONDERS, D. Craeye, R.W. Mays, R. Deans, K. Gijbels, Annelies BRONCKAERS, Piet STINISSEN, J. Pinxteren, et al.
- IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple Sclerosis(2015)
Authors: Bieke BROUX, Mark R. Mizee, Marjan VANHEUSDEN, Susanne VAN DER POL, Jack VAN HORSSEN, Bart VAN WIJMEERSCH, Veerle SOMERS, Helga E. DE VRIES, Piet STINISSEN, Niels HELLINGS
Pages: 2099 - 2109 - Cytomegalovirus: a culprit or protector in multiple sclerosis?(2015)
Authors: Marjan VANHEUSDEN, Piet STINISSEN, Bert A. 't HART, Niels HELLINGS
Pages: 16 - 23 - Abuse liability assessment in preclinical drug development: Predictivity of a translational approach for abuse liability testing using methylphenidate in four standardized preclinical study models(2014)
Authors: Greet TEUNS, Helena GEYS, Sonja M. A. Geuens, Piet STINISSEN, Theo MEERT
Pages: 295 - 309 - Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis(2014)
Authors: Rachel Knevel, Kerstin Klein, Klaartje SOMERS, Caroline Ospelt, Jeanne HOUWING-DUISTERMAAT, Jessica A. B. van Nies, Diederik P. C. de Rooy, Laura DE BOCK, Fina A. S. Kurreeman, Joris Schonkeren, et al.
Pages: 2038 - 2046 - Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptor(2014)
Authors: Kathleen Vrolix, Judith FRAUSSEN, Mario Losen, Jo Stevens, Peter C. Molenaar, Veerle SOMERS, Maria Alma Bracho, Rozen Le Panse, Piet STINISSEN, Sonia Berrih-Aknin, et al.
Pages: 101 - 112 - Circulating dendritic cells of multiple sclerosis patients are proinflammatory and their frequency is correlated with MS-associated genetic risk factors(2014)
Authors: Kristof THEWISSEN, Amber H. Nuyts, Nathalie Deckx, Bart VAN WIJMEERSCH, Guy Nagels, Marie D'hooghe, Barbara Willekens, Patrick Cras, Bert OP 'T EIJNDE, Herman Goossens, et al.
Pages: 548 - 557
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)